UNIGE document Scientific Article
previous document  unige:33528  next document
add to browser collection
Title

PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke

Authors
Published in Clinical Chemistry. 2005, vol. 51, no. 11, p. 2043-51
Abstract Plasma markers for stroke could be useful in diagnosis and prognosis and in prediction of response of stroke patients to therapy. PARK7 and nucleoside diphosphate kinase A (NDKA) are increased in human postmortem cerebrospinal fluid (CSF), a model of global brain insult, suggesting that measurement in CSF and, more importantly, in plasma may be useful as a biomarker of stroke.
Keywords Biological Markers/blood/cerebrospinal fluidCohort StudiesEnzyme-Linked Immunosorbent AssayEuropeHumansIntracellular Signaling Peptides and ProteinsNM23 Nucleoside Diphosphate KinasesNorth AmericaNucleoside-Diphosphate Kinase/blood/cerebrospinal fluidOncogene Proteins/blood/cerebrospinal fluidPlasmaProteome/analysisSensitivity and SpecificityStroke/blood/cerebrospinal fluid/diagnosis
Identifiers
PMID: 16141287
Full text
Article (Published version) (362 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe de Protéomique biomédicale (635)
Citation
(ISO format)
ALLARD, Laure et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. In: Clinical Chemistry, 2005, vol. 51, n° 11, p. 2043-51. doi: 10.1373/clinchem.2005.053942 https://archive-ouverte.unige.ch/unige:33528

371 hits

0 download

Update

Deposited on : 2014-01-22

Export document
Format :
Citation style :